• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用固定化的VIII:C异种抗血清研究VIII因子复合物的结构-功能。

Structure-function of the factor VIII complex studied with an immobilized heteroantisera to VIII:C.

作者信息

Cooper H A, Lee D, Lamb M A, Wagner R H

出版信息

Br J Haematol. 1980 Jan;44(1):149-60. doi: 10.1111/j.1365-2141.1980.tb01192.x.

DOI:10.1111/j.1365-2141.1980.tb01192.x
PMID:6769458
Abstract

An antibody was raised in rabbits to the small active fragment of human factor VIII, obtained by Ca2+ dissociation of a human factor VIII preparation made from a multidonor plasma pool. After absorption, the antibody neutralized the factor VIII coagulant activity of normal human plasma, but did not precipitate with any plasma or plasma fractions or neutralize von Willebrand factor (vwf) activity as measured by ristocetin aggregation of fixed washed platelets. Immune beads were prepared by CNBr binding of the partially purified rabbit antibody to 1% agarose beads. Non-immune beads were prepared with IgG fractions obtained from the rabbits before immunization and used throughout as a control. The amount of factor VIII coagulant activity (VII:C) removed from plasma by immune beads was time-dependent and proportional to the amount of beads used, but all of the VIII:C could not be readily removed. Removal of VIII:C by immune beads parallelled removal of factor VIII:antigen, but less VWF activity was removed. Immune beads could be blocked or saturated by treatment with large amounts of normal plasma, but not by von Willebrand disease plasma and only by some haemophilic plasma.

摘要

用人因子 VIII 的小活性片段免疫家兔制备抗体,该小活性片段是通过从多供体血浆库制备的人因子 VIII 制剂经 Ca2+ 解离获得的。吸收后,该抗体可中和正常人血浆中的因子 VIII 凝血活性,但不与任何血浆或血浆组分沉淀,也不中和用固定洗涤血小板的瑞斯托霉素聚集法测定的血管性血友病因子(vwf)活性。通过将部分纯化的兔抗体与 1% 琼脂糖珠进行溴化氰结合制备免疫珠。用免疫前从兔获得的 IgG 组分制备非免疫珠,并始终用作对照。免疫珠从血浆中去除的因子 VIII 凝血活性(VII:C)是时间依赖性的,且与所用珠的量成正比,但并非所有 VIII:C 都能轻易去除。免疫珠去除 VIII:C 与去除因子 VIII:抗原平行,但去除的 VWF 活性较少。用大量正常人血浆处理可封闭或饱和免疫珠,但血管性血友病血浆不能,只有一些血友病血浆能做到。

相似文献

1
Structure-function of the factor VIII complex studied with an immobilized heteroantisera to VIII:C.用固定化的VIII:C异种抗血清研究VIII因子复合物的结构-功能。
Br J Haematol. 1980 Jan;44(1):149-60. doi: 10.1111/j.1365-2141.1980.tb01192.x.
2
Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.对血管性血友病中缺乏的、血小板聚集所必需的一种血浆因子进行定量测定。与凝血因子VIII促凝活性及抗原含量的关系。
J Clin Invest. 1973 Nov;52(11):2708-16. doi: 10.1172/JCI107465.
3
Antibody nature of circulating inhibitor of plasma von Willebrand factor.血浆血管性血友病因子循环抑制剂的抗体性质
Proc Natl Acad Sci U S A. 1975 Oct;72(10):4167-71. doi: 10.1073/pnas.72.10.4167.
4
Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).血友病患者中抗凝血因子 VIII 促凝活性(VIII : C)的抑制剂对血清 VIII 因子相关抗原(VIII : AGN)/血管性血友病因子(VIII : vWf)的影响。
Thromb Haemost. 1981 Feb 23;45(1):68-72.
5
Precipitating anti-VIII:C antibodies in two patients with haemophilia A.两名甲型血友病患者体内的 VIII 因子促凝活性沉淀抗体
Br J Haematol. 1982 Jan;50(1):135-46. doi: 10.1111/j.1365-2141.1982.tb01898.x.
6
IgA inhibitor to factor VIII/von Willebrand factor.
Br J Haematol. 1985 Jan;59(1):149-58. doi: 10.1111/j.1365-2141.1985.tb02975.x.
7
Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.血浆胶原蛋白辅助因子与血管性血友病因子抗原及瑞斯托霉素辅因子相关,但与出血时间无关。
Thromb Haemost. 1988 Jun 16;59(3):485-90.
8
Binding of low-molecular-weight canine factor VIII coagulant from von Willebrand plasma to canine factor VIII-related antigen.来自血管性血友病血浆的低分子量犬因子VIII促凝剂与犬因子VIII相关抗原的结合。
Br J Haematol. 1981 Dec;49(4):541-50. doi: 10.1111/j.1365-2141.1981.tb07262.x.
9
The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor.人凝血因子VIII与血管性血友病因子结合的亲和力及化学计量关系。
Blood. 1995 Jun 1;85(11):3150-7.
10
An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.一种使用定义功能性表位的单克隆抗体对人因子VIII/血管性血友病因子(VIII:vWF)进行的免疫放射分析。
Br J Haematol. 1985 Apr;59(4):565-77. doi: 10.1111/j.1365-2141.1985.tb07350.x.